135 related articles for article (PubMed ID: 9188900)
1. Economic consequences of multiple sclerosis for Canadians.
Asche CV; Ho E; Chan B; Coyte PC
Acta Neurol Scand; 1997 May; 95(5):268-74. PubMed ID: 9188900
[TBL] [Abstract][Full Text] [Related]
2. Economic impact of cardiovascular disease in Canada.
Chan B; Coyte P; Heick C
Can J Cardiol; 1996 Oct; 12(10):1000-6. PubMed ID: 9191493
[TBL] [Abstract][Full Text] [Related]
3. The economic cost of otitis media in Canada.
Coyte PC; Asche CV; Elden LM
Int J Pediatr Otorhinolaryngol; 1999 Jun; 49(1):27-36. PubMed ID: 10428403
[TBL] [Abstract][Full Text] [Related]
4. Burden of illness of multiple sclerosis: Part I: Cost of illness. The Canadian Burden of Illness Study Group.
Can J Neurol Sci; 1998 Feb; 25(1):23-30. PubMed ID: 9532277
[TBL] [Abstract][Full Text] [Related]
5. The economic cost of musculoskeletal disorders in Canada.
Coyte PC; Asche CV; Croxford R; Chan B
Arthritis Care Res; 1998 Oct; 11(5):315-25. PubMed ID: 9830876
[TBL] [Abstract][Full Text] [Related]
6. The cost of obesity in Canada.
Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
[TBL] [Abstract][Full Text] [Related]
7. Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
da Silva NL; Takemoto MLS; Damasceno A; Fragoso YD; Finkelsztejn A; Becker J; Gonçalves MVM; Tilbery C; de Oliveira EML; Callegaro D; Boulos FC
BMC Health Serv Res; 2016 Mar; 16():102. PubMed ID: 27009599
[TBL] [Abstract][Full Text] [Related]
8. The socioeconomic consequences of multiple sclerosis: a controlled national study.
Jennum P; Wanscher B; Frederiksen J; Kjellberg J
Eur Neuropsychopharmacol; 2012 Jan; 22(1):36-43. PubMed ID: 21669514
[TBL] [Abstract][Full Text] [Related]
9. The economic impact of multiple sclerosis in Australia in 2010.
Palmer AJ; Colman S; O'Leary B; Taylor BV; Simmons RD
Mult Scler; 2013 Oct; 19(12):1640-6. PubMed ID: 23652216
[TBL] [Abstract][Full Text] [Related]
10. Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada.
Piwko C; Desjardins OB; Bereza BG; Machado M; Jaszewski B; Freedman MS; Einarson TR; Iskedjian M
Pain Res Manag; 2007; 12(4):259-65. PubMed ID: 18080044
[TBL] [Abstract][Full Text] [Related]
11. Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability.
Casado V; Martínez-Yélamos S; Martínez-Yélamos A; Carmona O; Alonso L; Romero L; Moral E; Gubieras L; Arbizu T
BMC Health Serv Res; 2006 Nov; 6():143. PubMed ID: 17078879
[TBL] [Abstract][Full Text] [Related]
12. The economic burden of end-stage renal disease in Canada.
Zelmer JL
Kidney Int; 2007 Nov; 72(9):1122-9. PubMed ID: 17700643
[TBL] [Abstract][Full Text] [Related]
13. [Cost of multiple sclerosis in France].
Fromont A; Lehanneur MN; Rollot F; Weill A; Clerc L; Bonithon Kopp C; Binquet C; Moreau T
Rev Neurol (Paris); 2014; 170(6-7):432-9. PubMed ID: 24856285
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis in Canada 2011 to 2031: results of a microsimulation modelling study of epidemiological and economic impacts.
Amankwah N; Marrie RA; Bancej C; Garner R; Manuel DG; Wall R; Finès P; Bernier J; Tu K; Reimer K
Health Promot Chronic Dis Prev Can; 2017 Feb; 37(2):37-48. PubMed ID: 28273039
[TBL] [Abstract][Full Text] [Related]
15. Estimate of the cost of multiple sclerosis in Spain by literature review.
Fernández O; Calleja-Hernández MA; Meca-Lallana J; Oreja-Guevara C; Polanco A; Pérez-Alcántara F
Expert Rev Pharmacoecon Outcomes Res; 2017 Aug; 17(4):321-333. PubMed ID: 28726515
[TBL] [Abstract][Full Text] [Related]
16. Direct and indirect costs of asthma in Canada, 1990.
Krahn MD; Berka C; Langlois P; Detsky AS
CMAJ; 1996 Mar; 154(6):821-31. PubMed ID: 8634960
[TBL] [Abstract][Full Text] [Related]
17. [Multiple sclerosis: cost of the illness].
Tissot E; Woronoff-Lemsi MC
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1169-74. PubMed ID: 11787352
[TBL] [Abstract][Full Text] [Related]
18. Societal costs of multiple sclerosis in Ireland.
Carney P; O'Boyle D; Larkin A; McGuigan C; O'Rourke K
J Med Econ; 2018 May; 21(5):425-437. PubMed ID: 29320900
[TBL] [Abstract][Full Text] [Related]
19. The economic cost of multiple sclerosis in Sweden in 1994.
Henriksson F; Jönsson B
Pharmacoeconomics; 1998 May; 13(5 Pt 2):597-606. PubMed ID: 17165326
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the burden of diabetes in Poland].
Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
